Also on the pharma beat, but in a negative way, was CBS' John Miller. He covered the Japanese-owned, India-based, Ranbaxy Laboratories, which is licensed by the Food & Drug Administration to produce generic Lipitor. Miller found Dinesh Thakur, a whistleblower, who stands to make $49m for exposing fraud in efficacy and safety testing in 15 of Ranbaxy's FDA applications to produce generic drugs.
You must be logged in to this website to leave a comment. Please click here to log in so you can participate in the discussion.